DVM
QCOR

Dreman Value Management’s QUESTCOR PHARMA INC QCOR Stock Holding History

Dreman Value Management’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-806
Closed -$52K – 528
2014
Q1 		$52K Buy
+806
New +$51.5K ﹤0.01% 371

Other funds holding QCOR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dreman Value Management's QCOR Position: Q2 2014 in Review

Dreman Value Management sold out of QUESTCOR PHARMA INC (QCOR) in Q2 2014, closing a stake of 806 shares — an estimated $52K sold.

Dreman Value Management first reported a position in QCOR in Q1 2014 and held it in 1 quarter. The position peaked at $52K in Q1 2014. 320 funds tracked by Wall St. Rank hold QCOR as of Q2 2014.

  • Dreman Value Management reported no remaining QUESTCOR PHARMA INC position as of Q2 2014 after selling out during the quarter.
  • Dreman Value Management sold 806 QUESTCOR PHARMA INC shares in Q2 2014, an estimated $52K.
  • Dreman Value Management first reported a position in QUESTCOR PHARMA INC in Q1 2014 and held it in 1 quarter.
  • Dreman Value Management's QUESTCOR PHARMA INC position peaked at $52K in Q1 2014.
  • 320 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q2 2014.

Based on Dreman Value Management's 13F filing for Q2 2014, filed 14 Aug 2014.